Trospium chloride is a muscarinic antagonist used to treat overactive bladder. It has side effects typical of this class of drugs, namely dry mouth, stomach...
18 KB (1,856 words) - 15:00, 2 October 2024
Xanomeline/trospium chloride, sold under the brand name Cobenfy, is a fixed-dose combination medication used for the treatment of schizophrenia. It contains...
16 KB (1,436 words) - 01:50, 2 October 2024
activity at the M1 and M4 subtypes. Xanomeline/trospium is an approved combination drug. Trospium chloride is a non-CNS penetrant non-selective muscarinic...
16 KB (1,497 words) - 14:55, 2 October 2024
Desmethylclozapine atropine Hyoscyamine scopolamine Diphenhydramine Dimenhydrinate trospium chloride dicycloverine tolterodine oxybutynin ipratropium mamba toxin MT7 mamba...
31 KB (2,714 words) - 18:27, 22 September 2024
Oxybutynin (redirect from Oxybutynin chloride)
first-pass hepatic effect that the oral formulations are subject to. Oxybutynin chloride is contraindicated in patients with untreated narrow angle glaucoma, and...
21 KB (1,816 words) - 03:55, 30 September 2024
Trimebutine Tripitamine (tripitramine) Tropacine Tropatepine Tropicamide Trospium chloride Typical antipsychotics (e.g., chlorpromazine, chlorprothixene, cyamemazine...
34 KB (3,196 words) - 06:07, 15 August 2024
adherence to treatment. The fixed-dose combination medication xanomeline/trospium chloride (Cobenfy) was approved for medical use in the United States in September...
172 KB (18,780 words) - 19:46, 27 September 2024
Acetylcholine (redirect from Acetylcholine chloride)
Trimebutine Tripitamine (tripitramine) Tropacine Tropatepine Tropicamide Trospium chloride Typical antipsychotics (e.g., chlorpromazine, chlorprothixene, cyamemazine...
41 KB (4,374 words) - 04:43, 17 September 2024
Trimebutine Tripitamine (tripitramine) Tropacine Tropatepine Tropicamide Trospium chloride Typical antipsychotics (e.g., chlorpromazine, chlorprothixene, cyamemazine...
117 KB (11,361 words) - 06:39, 30 September 2024
been proposed as a potential treatment for schizophrenia. Xanomeline/trospium chloride was approved in the US in 2024. Based on preclinical pharmacological...
9 KB (844 words) - 07:33, 30 September 2024